Quantum Genesis AI Corp. (FKA Quantumzyme Corp.) Reports Q2 2026 Financial Results

Key Highlights from the Latest SEC Filing

• Quarter Ended: January 31, 2026
• Ticker: Not specified in document
• Shares Outstanding (as of March 19, 2026): 40,972,050 common shares
• Business Status: Non-shell, emerging growth company
• Current Assets (Jan 31, 2026): \$59
• Total Assets (Jan 31, 2026): \$59
• Total Liabilities and Stockholders’ Deficit (Jan 31, 2026): \$59
• Net Loss per Share (Q2 2026): \$(0.12)
• Weighted Average Shares Outstanding (Q2 2026): 38,962,050
• Stockholders’ Deficit (Jan 31, 2026): \$(418,342)
• Cash Position: Minimal; net decrease in cash and no proceeds from stock issues in the period

Detailed Financial and Operational Analysis

Balance Sheet Overview

Quantum Genesis AI Corp. reported extremely limited current assets of only \$59 as of January 31, 2026, reflecting a precarious cash position. Total assets matched this amount, showing no material non-current asset holdings.

The company’s stockholders’ deficit deepened, with a total deficit of \$(418,342) at quarter-end. This is a deterioration from the previous year (July 31, 2025: \$(283,299)), highlighting ongoing and increasing financial strain.

Share Structure and Equity

• Common Stock: 40,972,050 shares outstanding as of March 19, 2026.
• Preferred Stock: 130,000,000 authorized; minimal issued and outstanding (500 Series B Preferred Shares, nominal value).
• No new common stock was issued for cash in the most recent quarter, and there was no inflow from equity financing.

Income Statement and Losses

The company reported a net loss per share of \$(0.12) for the quarter ended January 31, 2026. The weighted average number of shares used in the calculation was 38,962,050. This sustained level of losses continues a historical trend, with cumulative retained losses exceeding \$5.6 million.

Cash Flow and Liquidity

• Cash Flows from Financing Activities: No proceeds from the issuance of common stock this quarter, reflecting an inability to raise new equity capital.
• Supplemental Non-Cash Activities: \$3,200 worth of shares were issued to settle notes payable during the six months ended January 31, 2025, but there are no similar transactions in the current quarter.

The company’s ability to continue operations is entirely dependent on future fundraising. Management states there are currently no firm financing agreements in place, and warns that inability to secure capital will restrict growth, could force operational suspension, and might result in substantial dilution for existing shareholders should new equity be raised.

Key Investor Risks and Forward-Looking Statements

• Going Concern Risk: The company’s financial condition raises substantial doubt about its ability to continue as a going concern. If additional funds are not raised, the company may halt operations, resulting in potential loss for shareholders.
• Dilution Risk: Any additional equity financing is likely to substantially dilute current shareholders.
• No Revenue or Cash Flow: With almost no assets and no revenue reported, the company is entirely reliant on external financing.
• Regulatory and Reporting Compliance: The company remains current with SEC filing requirements and has submitted all Interactive Data Files as required.

Forward-looking statements include management’s plans to seek funding via equity or external sources, but these plans remain highly uncertain.

Potentially Price-Sensitive Information

Shareholders and potential investors should note:

• The company’s cash reserves are virtually exhausted, with only \$59 in current assets as of January 31, 2026.
• No new financing has been secured for the quarter, and there are no agreements in place for future funding.
• The deepening stockholders’ deficit and continued losses highlight an urgent need for capital, with a real risk of operational suspension if funds are not raised imminently.
• Any future financing is likely to be highly dilutive.

These facts are highly material and could significantly impact the share price, especially if the company is unable to secure near-term funding.

Conclusion

Quantum Genesis AI Corp. faces significant going concern risks, with minimal assets, deepening losses, and no immediate prospects for new funding. Shareholders should closely monitor for any announcements regarding capital raises or strategic partnerships, as these will be critical to the company’s survival and could have a major impact on share value.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. The author and publisher accept no liability for any actions taken based on this information.

View Quantum Genesis AI Corp. Historical chart here